CMap Candidate Details

Structure:
CMap ID: C30915
Pert ID: BRD-K89732114
Compound Name: trifluoperazine
Targets: DRD2
MoA: Dopamine receptor antagonist
SMILES: CN1CCN(CCCN2c3ccccc3Sc3ccc(cc23)C(F)(F)F)CC1
InchiKey: ZEWQUBUPAILYHI-UHFFFAOYSA-N
Compound Aliases: --

Score ID Pert ID Cell Line Pert Dose Pert Time Raw Score (GSE126848) Normalized Score (GSE126848) fdr_q_nlog10 (GSE126848) Raw Score (GSE135251) Normalized Score (GSE135251) fdr_q_nlog10 (GSE135251)
8029 BRD-K89732114 HT29 10 uM 6 h 0.0 0.0 0.0 -0.31 -1.05 0.7
9252 BRD-K89732114 A549 10 uM 6 h 0.0 0.0 0.0 0.0 0.0 0.0
9539 BRD-K89732114 AGS 10 uM 6 h 0.0 0.0 0.0 0.0 0.0 0.0
9846 BRD-K89732114 H1299 10 uM 6 h 0.0 0.0 0.0 0.24 0.86 0.16
10622 BRD-K89732114 HCT116 10 uM 6 h 0.0 0.0 0.0 0.31 1.1 0.68
11606 BRD-K89732114 NCIH2073 10 uM 6 h 0.0 0.0 0.0 0.0 0.0 0.0
11865 BRD-K89732114 NCIH508 10 uM 6 h 0.0 0.0 0.0 0.0 0.0 0.0
12163 BRD-K89732114 NCIH596 10 uM 6 h 0.0 0.0 0.0 0.25 0.9 0.22
12401 BRD-K89732114 NOMO1 10 uM 6 h 0.0 0.0 0.0 0.43 1.51 2.28
12894 BRD-K89732114 SW480 10 uM 6 h 0.25 1.02 0.13 0.0 0.0 0.0
13108 BRD-K89732114 THP1 10 uM 6 h 0.0 0.0 0.0 0.0 0.0 0.0
13389 BRD-K89732114 U937 10 uM 6 h 0.0 0.0 0.0 0.0 0.0 0.0
88146 BRD-K89732114 VCAP 20 uM 24 h 0.0 0.0 0.0 0.0 0.0 0.0
91073 BRD-K89732114 HUH7 8 uM 72 h 0.0 0.0 0.0 0.0 0.0 0.0
96903 BRD-K89732114 PC3 10 uM 24 h 0.0 0.0 0.0 0.0 0.0 0.0
99106 BRD-K89732114 NEU 10 uM 6 h 0.0 0.0 0.0 0.0 0.0 0.0
99258 BRD-K89732114 NPC 10 uM 6 h 0.0 0.0 0.0 0.0 0.0 0.0
114319 BRD-K89732114 U2OS 20 uM 6 h 0.0 0.0 0.0 0.0 0.0 0.0
116276 BRD-K89732114 A375 10 uM 24 h 0.23 0.95 0.06 0.0 0.0 0.0
116363 BRD-K89732114 HA1E 10 uM 24 h 0.0 0.0 0.0 0.34 1.2 1.11
116407 BRD-K89732114 HCC515 10 uM 24 h 0.18 0.74 0.0 0.0 0.0 0.0
116456 BRD-K89732114 HEPG2 10 uM 24 h 0.0 0.0 0.0 0.0 0.0 0.0
116557 BRD-K89732114 MCF??7.00 10 uM 24 h 0.0 0.0 0.0 0.0 0.0 0.0
121646 BRD-K89732114 HELA 10 uM 24 h 0.0 0.0 0.0 0.0 0.0 0.0
121711 BRD-K89732114 YAPC 10 uM 24 h 0.0 0.0 0.0 0.0 0.0 0.0
The GSE89632 and GSE126848 datasets are hepatic gene expression profiles of nonalcoholic fatty liver disease (NAFLD).